This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Sehgal, A. et al. Lancet Oncol. https://doi.org/10.1016/S1470-2045(22)00339-4 (2022)
Related article
Kamdar, M. et al. Lancet https://doi.org/10.1016/S0140-6736(22)00662-6 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Liso-cel effective in R/R LBCL. Nat Rev Clin Oncol 19, 567 (2022). https://doi.org/10.1038/s41571-022-00673-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00673-7